Cargando…
Recent Progress of Nanocarrier-Based Therapy for Solid Malignancies
SIMPLE SUMMARY: Although conventional anti-cancer drugs have been the footstone in the fight against cancer, yet they are far from optimal due to issues related with indiscriminate destruction of normal cells, multidrug resistance, and toxicity, as a result, a more selective therapy is urgently need...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600685/ https://www.ncbi.nlm.nih.gov/pubmed/32998391 http://dx.doi.org/10.3390/cancers12102783 |